Additionally, OncoPrint results indicate that JAK2, STAT1, IRF-1, and PD-L1 genes were altered or overexpressed in about 24%, 20%, 24%, and 27% of EBV (+) GC tissues, respectively. This evidence concerns the gene JAK2 and gastric cancer.